Tradestie Institutional Equity Comparison Engine

BHST vs PBM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PBM Overall Edge

PBM Captures Institutional Edge (2โ€“0 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Psyence Biomedical Ltd. Common Shares (PBM) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, BHST trades at N/M Forward P/E with -18.0% operating margin (+3.8% YoY revenue) versus PBM at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PBM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BHST N/M vs PBM N/M Fwd P/E
Growth & Margin Winner PBM
Op Margin -18.0% vs 0.0% ยท YoY +3.8% vs +0.0%
Momentum & Technical Winner PBM
1Y -79.4% vs +6.5% ยท 52W Pos 6% vs 14%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
1M Return -22.62%
1Y Return -79.4%
Forward P/E N/M
Unified AI Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
PBM NASDAQ
Psyence Biomedical Ltd. Common Shares
Pharmaceutical Preparations
$2.97
+3.85% 1D
Market Cap $12.0M
1M Return -27.91%
1Y Return +6.45%
Forward P/E N/M
Unified AI Score
63.9 / 100 BUY
Tech 88.0 Fund 64.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BHST -79.4% PBM +6.45% Spread: +85.85 pp (PBM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BHST TTM Op. Margin: -18.0% PBM TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHST vs PBM. Trailing 12-month operating profitability (BHST -18.0% vs PBM 0.0%) and valuation multiples (BHST N/M vs PBM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BHST (3) vs PBM (5)
Institutional Metric BHST PBM Criterion Row Winner
Market Capitalization Scale $29.9M $12.0M Larger Scale BHST
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +3.8% +0.0% Higher Growth BHST
Operating Margin (TTM) Profitability -18.0% 0.0% Higher Margin PBM
Net Profit Margin Profitability -31.2% 0.0% Higher Margin PBM
Return on Equity (ROE) Capital Efficiency -142.5% -58.6% Higher ROE PBM
52-Week Range Position Momentum 6% ($1โ€“$7) 14% ($1โ€“$17) Stronger Trend PBM
Beta / 30D Volatility Risk Regime 0.25ฮฒ ยท 86% Vol 1.13ฮฒ ยท 124% Vol Lower Realized Risk BHST
Unified Institutional Score Composite Signal 58.2 / 100 (HOLD) 63.9 / 100 (BUY) Higher Composite PBM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BHST vs PBM Buy Guide
BHST UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BHST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PBM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PBM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BHST nor PBM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.